咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Low-fluence photodynamic thera... 收藏

Low-fluence photodynamic therapy combinations in the treatment of exudative age-related macular degeneration

Low-fluence photodynamic therapy combinations in the treatment of exudative age-related macular degeneration

作     者:Taylan Ozturk Hakan Oner Ali Osman Saatci Suleyman Kaynak 

作者机构:Department of OphthalmologyDr.Behet Uz Children's HospitalIzmirTurkey Department of OphthalmologySchool of MedicineDokuz Eylul University IzmirTurkey 

出 版 物:《International Journal of Ophthalmology(English edition)》 (国际眼科杂志(英文版))

年 卷 期:2012年第5卷第3期

页      面:377-383页

核心收录:

学科分类:1002[医学-临床医学] 100212[医学-眼科学] 10[医学] 

主  题:age-related macular degeneration photodynamic therapy low-fluence photodynamic therapy anti-VEGF 

摘      要:AIM:To compare the efficacy of low-fluence photodynamic therapy(PDT) combinations in the treatment of age-related macular degeneration(AMD).· METHODS:Forty-five previously untreated eyes of 45 patients with exudative AMD whose best-corrected visual acuity(BCVA) was ≥0.3(Snellen) were enrolled.15 patients in Group I underwent low-fluence PDT(25J/cm2-300mW/cm2-83sec) and intravitreal pegaptanib combination,15 patients in Group II underwent PDT(50J/cm2-600mW/cm2-83sec) and intravitreal pegaptanib combination while,15 patients in Group III underwent intravitreal pegaptanib *** ophthalmologic examinations were performed in pre and post treatment visits,and the results were statistically analised.A clinical activity score(CAS) was calculated by using changes in lesion size,amount of hemorrhage,staining pattern in FA and OCT measurement of intra/subretinal fluid.≤3 logMAR lines of decrease in BCVA and decrease in CAS were considered as successful treatment.· RESULTS:The mean age of 19 female(42.2%) and 26 male(57.8%) patients was(72.82±8.02) *** follow-up was(13.93±5.87) *** type was occult in 28 eyes(62.2%).Treatment success rates according to BCVA assessments were 86.7%,80%,60% and mean BCVA decrease were 0.3,1.0,2.2 logMAR lines in Group I,II and III,respectively(P 0.05).According to the changes in central macular thickness and CAS,no difference was found among the study groups(P =0.850 and P =0.811,respectively).Patients treated with combination regimens had lower intravitreal injection frequencies(P =0.015).· CONCLUSION:Combination regimen with intravitreal pegaptanib and low-fluence PDT seems to be safe and effective in stabilizing the clinical activity and BCVA in exudative AMD.·

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分